P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY

Bibliographic Details
Main Authors: Dao-Xing Deng, Meng-Zhu Shen, Xiao-Hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Yu-Hong Chen, Huan Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Xiao-Jun Huang, Xiao-Dong Mo
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000972056.91461.24
_version_ 1827332466763890688
author Dao-Xing Deng
Meng-Zhu Shen
Xiao-Hui Zhang
Lanping Xu
Yu Wang
Chen-Hua Yan
Yu-Hong Chen
Huan Chen
Wei Han
Feng-Rong Wang
Jing-Zhi Wang
Xiao-Jun Huang
Xiao-Dong Mo
author_facet Dao-Xing Deng
Meng-Zhu Shen
Xiao-Hui Zhang
Lanping Xu
Yu Wang
Chen-Hua Yan
Yu-Hong Chen
Huan Chen
Wei Han
Feng-Rong Wang
Jing-Zhi Wang
Xiao-Jun Huang
Xiao-Dong Mo
author_sort Dao-Xing Deng
collection DOAJ
first_indexed 2024-03-07T17:00:23Z
format Article
id doaj.art-cca90d46754846868c2be7ecdf584588
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:00:23Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-cca90d46754846868c2be7ecdf5845882024-03-03T03:25:30ZengWileyHemaSphere2572-92412023-08-017e914612410.1097/01.HS9.0000972056.91461.24202308003-01188P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDYDao-Xing Deng0Meng-Zhu Shen1Xiao-Hui Zhang2Lanping Xu3Yu Wang4Chen-Hua Yan5Yu-Hong Chen6Huan Chen7Wei Han8Feng-Rong Wang9Jing-Zhi Wang10Xiao-Jun Huang11Xiao-Dong Mo121 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000972056.91461.24
spellingShingle Dao-Xing Deng
Meng-Zhu Shen
Xiao-Hui Zhang
Lanping Xu
Yu Wang
Chen-Hua Yan
Yu-Hong Chen
Huan Chen
Wei Han
Feng-Rong Wang
Jing-Zhi Wang
Xiao-Jun Huang
Xiao-Dong Mo
P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
HemaSphere
title P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
title_full P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
title_fullStr P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
title_full_unstemmed P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
title_short P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
title_sort p1292 basiliximab may be the potential solution for severe liver chronic graft versus host disease a prospective pilot study
url http://journals.lww.com/10.1097/01.HS9.0000972056.91461.24
work_keys_str_mv AT daoxingdeng p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT mengzhushen p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT xiaohuizhang p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT lanpingxu p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT yuwang p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT chenhuayan p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT yuhongchen p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT huanchen p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT weihan p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT fengrongwang p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT jingzhiwang p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT xiaojunhuang p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy
AT xiaodongmo p1292basiliximabmaybethepotentialsolutionforsevereliverchronicgraftversushostdiseaseaprospectivepilotstudy